Chelation Therapy and CV Risk: Why TACT2 Showed No Benefit

Professor of Medicine, Columbia University Irving Medical Center; Chairman of Medicine, Eugene Sayfie Chief of Cardiology, Columbia University Division of Cardiology at Mount Sinai, Mount Sinai Medical Center of Florida, Miami Beach, FloridaTricia Ward:

What is chelation? A chelating agent is a chemical compound that has a particular shape with a pocket. It's like a baseball mitt with a magnet in it. The one that we're talking about is ethylenediaminetetraacetic acid , or edetate disodium, which is the US Food and Drug Administration designation. , which ran from 2003 until 2012. This study has exactly the same design.

We had this surprise result with an 18% relative risk reduction in all-comers with a prior heart attack that was statistically significant, and a spectacular 41% relative risk reduction in the patients who had diabetes. The FDA said,"Well, this is very interesting. Why don't you do it again?" started. The first patient was randomized in 2016. We randomized 1000 patients.

Cardiovascular Risk CV Risk Factors Cardiovascular Risk Factors Cardiovascular Risk Management Toxicology Toxicity Poisoning Toxins Diabetes Mellitus Type 2 Diabetes Mellitus Type Ii Type 2 Diabetes Type 2 DM T2DM T2D Chelation Therapy Medical Conferences Professional Societies Jobs Career Profession Employment Job Interview Job Contract Employment Contract New York

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Chelation Therapy Not Associated with Reduction in Cardiovascular EventsA new study has found that chelation therapy, used to remove lead from the blood, does not reduce cardiovascular events. This is in contrast to a previous study that showed a reduction in cardiovascular events with the therapy. The difference in results may be due to lower blood lead levels in the patients enrolled in the new trial.
Source: Medscape - 🏆 386. / 55 Read more »

Chelation Therapy Provides No Benefit Post-MIChelation therapy to remove potentially toxic levels of lead was not associated with a reduction in CV events in post-MI patients with diabetes in the TACT2 trial.
Source: Medscape - 🏆 386. / 55 Read more »

Personal Perspective: Psychodrama therapy gave me 10 years of therapy in 1 day.A Personal Perspective: Psychodrama is a form of group therapy. Individuals process their childhood traumas by acting out early memories together and rewriting their family stories.
Source: PsychToday - 🏆 714. / 51 Read more »

Ovarian Cancer: Predicting Risk for Secondary Leukemia after PARPi TherapyA new study pinpointed potential predictive factors for secondary myelodysplastic syndrome or acute myeloid leukemia after PARP inhibitor therapy in women with ovarian cancer.
Source: Medscape - 🏆 386. / 55 Read more »

Statin Therapy Increases Risk of Diabetes Diagnosis, but Cardiovascular Benefit OutweighsNew data suggests that statin therapy increases the risk of diabetes diagnosis among individuals without diabetes at baseline. However, the cardiovascular benefit of statin therapy outweighs this risk.
Source: Medscape - 🏆 386. / 55 Read more »

Therapy dog program for students at risk as CUSD faces $2.3M deficitMadison Weil is a multimedia journalist for ABC 10News.
Source: 10News - 🏆 732. / 50 Read more »